Want to see MAGN full AI Analyst Report?
Top Page
Magnera
(NYSE:MAGN)
Select Model
Select Model
Rating:49Neutral
Price Target:
$13.00
▲(5.43% Upside)
Action:Reiterated
Date:08/08/26
MAGN’s score is held back primarily by weak financial quality (ongoing net losses, thin gross margins, and elevated leverage) despite strong revenue growth and improved operating/cash-flow performance. Technicals are neutral with a mixed moving-average picture and modestly positive MACD. Valuation is penalized by a negative P/E and no dividend yield data. The latest earnings call was moderately supportive due to reaffirmed free cash flow guidance and synergy progress, but inflation and a lower-end EBITDA outlook temper the upside.
Positive Factors
Strong Revenue Growth & Improving Operating Profitability
Sustained TTM top-line growth of ~55% and improving operating/EBITDA margins indicate durable demand and successful commercial execution. Over 2–6 months this supports scale economies, better fixed-cost absorption and the ability to fund integration or innovation investments that can cement competitive position.
Negative Factors
Ongoing Net Losses and Negative ROE
Persistent net losses and negative ROE signal that profitability improvements remain incomplete. Over the medium term, continued bottom-line deficits can erode equity, limit retained-earnings funded growth and raise the bar for management to convert operational gains into durable shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth & Improving Operating Profitability
Sustained TTM top-line growth of ~55% and improving operating/EBITDA margins indicate durable demand and successful commercial execution. Over 2–6 months this supports scale economies, better fixed-cost absorption and the ability to fund integration or innovation investments that can cement competitive position.
Read all positive factors
Magnera (MAGN) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$427.09M
Dividend Yield8.14%
Average Volume (3M)455.43K
Price to Earnings (P/E)―
Beta (1Y)1.17
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees8,500
SectorGeneral
Sector StrengthN/A
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-3.13
Shares Outstanding35,800,000
10 Day Avg. Volume352,957
30 Day Avg. Volume455,429
Financial Highlights & Ratios
PEG Ratio-1.55
Price to Book (P/B)0.37
Price to Sales (P/S)0.12
P/FCF Ratio10.88
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$16.00Price Target Upside29.76% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.93
Revenue Forecast (FY)$3.40B
Magnera Business Overview & Revenue Model
Company Description
Magnera Corporation manufactures and sells non-woven and related products worldwide. It sells its products primarily into consumer-oriented end markets, such as healthcare, and personal care. The company offers personal care and consumer solution ...
Magnera Earnings Call Summary
Earnings Call Date:Aug 05, 2026
(Q3-2026)
| % Change Since: |
Next Earnings Date:Nov 25, 2026
Earnings Call Sentiment Positive
The call emphasized strong execution: revenue of $857M, adjusted EBITDA up 9% to $99M, realization of full run-rate Project CORE and merger synergies, a successful product launch (Universa), and reaffirmed free cash flow guidance and robust liquidity. Offsetting these positives were persistent raw material inflation with pricing lag in Rest of World, a negative free cash flow quarter, demand softness in Europe, and management lowering adjusted EBITDA outlook to the low end of the prior range. Overall, the operational and strategic progress appears to outweigh the near-term inflation and regional headwinds.Positive Updates
Strong Quarterly Financials
Revenue of $857 million and adjusted EBITDA of $99 million for the quarter; adjusted EBITDA increased 9% year-over-year and earnings grew 9% with a 70 basis point improvement in margin versus the prior-year quarter.
Negative Updates
Raw Material Inflation and Pricing Lag in Rest of World
Raw material inflation accelerated meaningfully during the quarter. Pricing actions were implemented but there was a timing lag in Rest of World (RoW) causing under-recovered costs; management noted a few million dollars of catch-up expected to flow in Q4 and RoW adjusted EBITDA declined slightly year-over-year.
Read all updates
Q3-2026 Updates
Positive
Negative
Strong Quarterly Financials
Revenue of $857 million and adjusted EBITDA of $99 million for the quarter; adjusted EBITDA increased 9% year-over-year and earnings grew 9% with a 70 basis point improvement in margin versus the prior-year quarter.
Read all positive updates
Company Guidance
Management reaffirmed full-year free cash flow of approximately $90–$110 million while moving adjusted EBITDA guidance to the lower end of the previously communicated range; for context, Q3 revenue was $857 million with adjusted EBITDA of $99 million (up 9% year‑over‑year and +70 bps vs. prior‑year quarter). They reiterated a pro‑forma adjusted EBITDA target of $405 million once final synergies and Project CORE are fully realized (versus an earlier pro‑forma near $445 million), expect roughly $20 million of run‑rate synergies/CORE to carry into fiscal 2027, and indicated pricing actions should largely flow through in Q4 (with a “couple million” lag in Rest of World to be recovered). CapEx is tracking below the prior ~$80 million guide to a rough run‑rate of ~$60 million, quarter free cash flow was negative but better than forecast, available liquidity is about $575 million, and TSA exit/integration costs will taper as the TSA ends by year‑end 2026.Magnera Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
38
Negative
Cash Flow
58
Neutral
| Breakdown | TTM | Sep 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.28B | 3.20B | 2.19B | 1.39B | 1.49B | 1.08B |
| Gross Profit | 360.00M | 287.00M | 237.00M | 129.71M | 148.80M | 144.79M |
| EBITDA | 186.00M | 190.00M | 236.00M | 56.89M | -104.46M | 87.45M |
| Net Income | -112.00M | -159.00M | -154.00M | -79.05M | -194.21M | 6.94M |
Balance Sheet | ||||||
| Total Assets | 3.83B | 3.99B | 2.81B | 1.56B | 1.65B | 1.88B |
| Cash, Cash Equivalents and Short-Term Investments | 280.00M | 305.00M | 230.00M | 50.27M | 110.66M | 138.44M |
| Total Debt | 1.96B | 2.02B | 2.06B | 865.38M | 849.60M | 787.36M |
| Total Liabilities | 2.82B | 2.92B | 668.00M | 1.31B | 1.33B | 1.34B |
| Stockholders Equity | 1.02B | 1.06B | 2.14B | 256.85M | 318.00M | 542.76M |
Cash Flow | ||||||
| Free Cash Flow | 113.00M | 36.00M | 120.00M | -59.39M | -78.56M | 40.94M |
| Operating Cash Flow | 172.00M | 103.00M | 192.00M | -25.62M | -40.82M | 70.98M |
| Investing Cash Flow | -52.00M | -8.00M | -39.00M | -37.10M | -33.10M | -489.77M |
| Financing Cash Flow | -114.00M | -21.00M | -109.00M | -949.00K | 46.92M | 462.35M |
Magnera Technical Analysis
Negative
12.33
Price Trends
12.79
Negative
11.99
Negative
12.43
Negative
Market Momentum
-0.19
Positive
37.76
Neutral
22.97
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MAGN, the sentiment is Negative. The current price of 12.33 is above the 20-day moving average (MA) of 12.30, below the 50-day MA of 12.79, and below the 200-day MA of 12.43, indicating a bearish trend. The MACD of -0.19 indicates Positive momentum. The RSI at 37.76 is Neutral, neither overbought nor oversold. The STOCH value of 22.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MAGN.
Magnera Risk Analysis
Magnera disclosed 32 risk factors in its most recent earnings report. Magnera reported the most risks in the "Macro & Political" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Magnera Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $558.99M | 20.66 | 5.27% | 3.48% | 4.20% | ― | |
58 Neutral | $308.19M | 26.94 | 54.83% | 3.83% | -84.51% | -87.88% | |
56 Neutral | $225.17M | 25.60 | 3.64% | ― | 14.30% | -49.26% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | $374.04M | -14.99 | -27.57% | ― | ― | ― | |
49 Neutral | $427.09M | -3.71 | -10.77% | 8.14% | ― | ― |
* General Sector Average
MAGN
Magnera
11.61
0.26
2.29%
HDSN
Hudson Tech
5.32
-4.79
-47.38%
IPI
Intrepid Potash
41.26
11.80
40.05%
MSB
Mesabi Shs
23.25
-7.45
-24.26%
LZM
Lifezone Metals
4.04
-0.46
-10.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.